Page 6,762«..1020..6,7616,7626,7636,764..6,7706,780..»

National Advocacy Organization Elects Pavillon's CEO Anne Vance to its Board of Directors

Posted: Published on June 18th, 2012

More Topics: Choose a Sector Accounting Firms Advertising/Media/Communications Capital CEO/Board General Business Health/Biotech Internet/Technology Investment Firms Law Firms Mergers & Acquisitions Money Managers People Private Companies Public Companies Venture Capital Posted June 18, 2012 MILL SPRING, N.C., -- The National Association of Addiction Treatment Providers, (NAATP) has elected Anne Vance of Pavillon Treatment Center in North Carolina to its board of directors. Ms. Vance is CEO of the 80-bed not-for-profit residential and outpatient center in Western North Carolina, about 45 minutes from Asheville. She represents one of few women elected to the 20-member board. Pavillon is a nationally recognized addiction treatment and recovery center, having successfully treated hundreds of individuals and families from around the nation and overseas since 1996. Board members are elected by a team of peers and fellow members, representing over 830 individuals from around the nation. All officers serve a three-year term. "Since it is often the administrator or CEO who creates and sustains the vision of a treatment center, it is significant that Anne has achieved this deserved honor. She will continue to effectively represent Pavillon and the addiction treatment industry as well as she has for many years," said Bob Hayes, Jr., board chairman … Continue reading

Posted in MS Treatment | Comments Off on National Advocacy Organization Elects Pavillon's CEO Anne Vance to its Board of Directors

Stemtech: Stem cell nutrition could eclipse antioxidant supplement market

Posted: Published on June 18th, 2012

The emerging field of stem cell nutrition has the potential to eclipse the massive antioxidant supplement business according to the boss of the Californian firm responsible for creating a completely new category in nutritional supplements. Ray Carter Jr, CEO of Stemtech International, was speaking to NutraIngredients-USA after signing a multi-million dollar deal with Australian biotech firm Marinova to include its proprietary Fucoidan ingredients in Stemtechs new SE2 supplement. The next generation of Stemtechs best-selling StemEnhance supplement, SE2 also includes a concentrate of blue-green algae Aphanizomenon flos-aquae (AFA), the herb Polygonum multiflorum and the fungus Cordyceps sinensis. Adult stem cells, tissue maintenance and repair SE2 helps increase the number of adult stem cells or master cells that are released into the bloodstream before migrating into tissues where they reproduce and become new healthy cells, effectively helping the body renew and repair itself, claimed Carter. Stemtech products have already generated more than $200m in sales since 2005, he added: Stem cell nutrition addresses a brand new way to support health [and]has the potential to eclipse the massive antioxidant supplement business. When consumers first heard the words stem cell, they were inundated with media reports about the controversy and promise of embryonic stem … Continue reading

Posted in Stem Cell Research | Comments Off on Stemtech: Stem cell nutrition could eclipse antioxidant supplement market

19 Connecticut-based researchers awarded $9.8 million in stem cell research funding (document)

Posted: Published on June 18th, 2012

HARTFORD Nineteen Connecticut-based researchers have been awarded $9.8 million in stem cell research funds, Gov. Dannel P. Malloy announced in a statement today. Connecticuts continued support of stem cell research has allowed for exciting and innovative research to take place right here in our state, Malloy said. The research projects funded by these grants allow scientists to do revolutionary work that puts Connecticut at the forefront of bioscience industry. The awards were made by the State of Connecticut Stem Cell Research Advisory Committee at its grant review meeting week in Farmington. The projects funded by these grants will advance the clinical use of stem cells to treat some of the most debilitating diseases and injuries, stated Department of Public Health Commissioner and Advisory Committee Chairperson Dr. Jewel Mullen. The research conducted as a result of these grants brings hope to people coping with difficult health conditions. Eighty-eight stem cell funding applications were accepted for consideration in January 2012. The Connecticut Stem Cell Research Peer Review Committee reviewed these applications in accordance with National Institutes of Health guidelines and provided to the Advisory Committee its recommendations with respect to the scientific merits of each application. List of Connecticut-Based Researchers See the … Continue reading

Posted in Stem Cell Research | Comments Off on 19 Connecticut-based researchers awarded $9.8 million in stem cell research funding (document)

Sistemic to Moderate Regenerative Medicine Panel at 2012 Bio International Convention

Posted: Published on June 18th, 2012

BOSTON--(BUSINESS WIRE)-- Sistemic Ltd., a leading provider of microRNA-based problem-solving services and kit-based products to the Cell Therapy community, announced today that chairman and CEO Jim Reid is moderating a panel discussion at the 2012 Bio International Convention on Wednesday, June 20, in Boston. Featuring leaders from the regenerative medicine space, the panel is titled Stem Cell Therapies Fact or Fiction, and will share the lessons learned to-date from Scottish, European and American perspectives on the path to successfulcommercialization of stem cell therapies. Jim Reid, Sistemic CEO, commented, "Sistemic is very active in the CellTherapyarena and aremembersof Alliance for Advanced Therapies (AAT) and the Alliance for Regenerative Medicine (ARM). We see the ability to raise this topic at the leading world event, BIO 2012, as animportantstep on the path to commercialization of these products which will be transformational in healthcare, and bring hope and cures to many people around the globe." More information on the panel at BIO 2012: What: Panel Discussion Featuring Leaders in the Regenerative Medicine Space When: Wednesday, June 20, 3:00PM EDT Where: Boston Convention Center, Room 254A Who: Leaders of the Regenerative Medicine space: Panel objectives include evaluating lessons learned and best practice including from the … Continue reading

Comments Off on Sistemic to Moderate Regenerative Medicine Panel at 2012 Bio International Convention

Nanoparticle Exposure Linked To Rheumatoid Arthritis And Other Autoimmune Diseases

Posted: Published on June 18th, 2012

Editor's Choice Academic Journal Main Category: Arthritis / Rheumatology Also Included In: Immune System / Vaccines Article Date: 18 Jun 2012 - 7:00 PDT Current ratings for: 'Nanoparticle Exposure Linked To Rheumatoid Arthritis And Other Autoimmune Diseases' 4 (1 votes) Findings from the study, conducted by researchers at Trinity College Dublin, indicate that there are health and safety implications for the manufacture, utilization, and disposal of nanotechnology products and materials. Smoking, carbon particles emitted by car exhaust, and inhalation of dust over the long-term are all risk factors which cause chronic inflammation of the lungs. In addition, researchers have also established an association between smoking and autoimmune diseases, such as rheumatoid arthritis. In this study, the authors identified similar risks cause by nanotechnology products, which may produce new types of airborne pollutants that can impact global health if not handled appropriately. In order to determine whether there was a common underlying mechanism contributing to the development of autoimmune diseases in human cells when exposed to nanoparticles, Professor of Molecular Medicine Yuri Volkov and his Nanomedicine and Molecular Imaging team at Trinity College Dublin's School of Medicine, applied a wide range of nanomaterials to human cells derived from the lining of … Continue reading

Comments Off on Nanoparticle Exposure Linked To Rheumatoid Arthritis And Other Autoimmune Diseases

Stem Cell Therapy for CMT – Gary B-part 1 – Video

Posted: Published on June 18th, 2012

17-06-2012 02:12 Gary B. Stem Cell Therapy for CMT - For more info. visit Read the rest here: Stem Cell Therapy for CMT - Gary B-part 1 - Video … Continue reading

Comments Off on Stem Cell Therapy for CMT – Gary B-part 1 – Video

Royal Oak Veterinarian Dr. Simon First in Michigan to Offer In-House Adult Pet Stem Cell Therapy

Posted: Published on June 18th, 2012

ROYAL OAK, Mich., June 17, 2012 (GLOBE NEWSWIRE) -- Woodside Animal Hospital announced they have added both stem cell therapy and cold laser therapy to their suite of services. These two cutting edge treatments are done entirely in-house, no third-party lab work is required. Royal Oak veterinarian Dr. John Simon is the first Michigan veterinarian to provide pets with in-house adult stem cell therapy. The stem cells are derived from the pet's fat deposits and absolutely no embryonic tissue is used. "As a holistic veterinarian, I am committed to providing high quality, cutting-edge care that combines traditional veterinary care with advanced holistic treatments," said Dr. Simon. "Our in-house stem cell therapy and cold laser therapy procedures alleviate pain in limping dogs and promote internal healing following an injury. I also recommend these procedures for pets with osteoarthritis." Cold laser therapy is a non-surgical approach to pain management. Holistic equine veterinarians have used the procedure for over 20 years to treat injuries and joint pain. Today, veterinarians are using cold laser therapy to provide natural pain relief for injured pets. According to Dr. Simon, cold laser therapy works by using a low-level energy beam to penetrate just below the skin's surface. … Continue reading

Comments Off on Royal Oak Veterinarian Dr. Simon First in Michigan to Offer In-House Adult Pet Stem Cell Therapy

Stroke Treatment Using Stem Cells Shows Early Promise In Controversial Trial

Posted: Published on June 18th, 2012

Featured Article Main Category: Stroke Also Included In: Stem Cell Research;Neurology / Neuroscience Article Date: 18 Jun 2012 - 0:00 PDT Current ratings for: 'Stroke Treatment Using Stem Cells Shows Early Promise In Controversial Trial' 4.67 (3 votes) 4 (2 votes) The hope is that the treatment, by repairing damaged brain tissue, will one day help stroke patients regain some movement and ability to speak. Even small improvements can make a big difference to a person who has been robbed of the ability to wash, dress and feed themselves. The PISCES trial (Pilot Investigation of Stem Cells in Stroke) study, which is based in Scotland at the Institute of Neurological Sciences, Southern General Hospital, Greater Glasgow and Clyde NHS Board, is the first in the world to evaluate genetically engineered neural stem cells in people with disabling ischemic stroke. The researchers presented the interim results at the 10th Annual Meeting of the International Society for Stem Cell Research (ISSR), which took place from 13 to 16 June 2012, in Yokohama, Japan. The lead investigator of the trial is Professor Keith Muir, SINAPSE Professor of Clinical Imaging, Division of Clinical Neurosciences at the University of Glasgow. He told the press: "We … Continue reading

Comments Off on Stroke Treatment Using Stem Cells Shows Early Promise In Controversial Trial

Stem Cell Therapy for CMT – Gary B-part 1 – Video

Posted: Published on June 18th, 2012

17-06-2012 02:12 Gary B. Stem Cell Therapy for CMT - For more info. visit Original post: Stem Cell Therapy for CMT - Gary B-part 1 - Video … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Stem Cell Therapy for CMT – Gary B-part 1 – Video

Dads struggle with child's autism, embrace parenting

Posted: Published on June 18th, 2012

By Helena Oliviero The Atlanta Journal-Constitution Scott Carroll always knew something was not quite right with his toddler son, Cody. A fitful sleeper, Cody slept with his head tilted backward. He fidgeted, clenched his fists, barely spoke. Maybe it was acid reflux or fluid in the ears. It could be lots of things. But for Carroll, there was one thing it couldnt be autism. Id lay in bed and my heart just kept saying No. No. No, Carroll said. Even after the official diagnosis, Carroll cried and asked God if he were being punished. Would Cody ever graduate from high school? ... Would we ever ride four-wheelers together? ... Would Cody ever ride a bike? Carroll asked himself over and over. But over time, Carroll, 43, worked through his feelings and became more engaged. He started bringing Cody, a child with blue eyes and an easy smile, to speech and other therapies. And he discovered new ways to connect to his younger child. Read more here: Dads struggle with child's autism, embrace parenting … Continue reading

Comments Off on Dads struggle with child's autism, embrace parenting

Page 6,762«..1020..6,7616,7626,7636,764..6,7706,780..»